Jonathan De Pass
Founder and Chairman
Radiology
Daiichi Radioisotope Laboratories
Japan
Biography
Dr de Pass, a world-recognized leader in market intelligence and analysis for the life science sector, has led the way in creating new industry standards for forecasting global drug sales and other performance metrics. Prior to founding EvaluatePharma in 1996, Dr. de Pass was a top-ranked pharmaceutical analyst in the London investment-banking arena, where his insights guided venture capital and securities investments. He earned a Masters in Management from the London Business School, and Bachelor of Medicine and Bachelor of Surgery degrees from the University of Bristol in the U.K.
Research Interest
Dr de Pass, a world-recognized leader in market intelligence and analysis for the life science sector, has led the way in creating new industry standards for forecasting global drug sales and other performance metrics. Prior to founding EvaluatePharma in 1996, Dr. de Pass was a top-ranked pharmaceutical analyst in the London investment-banking arena, where his insights guided venture capital and securities investments. He earned a Masters in Management from the London Business School, and Bachelor of Medicine and Bachelor of Surgery degrees from the University of Bristol in the U.K.
